Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 11Terminated 3Active not recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Breast 1

Conditions

Sarcoma 1Prostatic Neoplasms 1Lymphatic Metastasis 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

pembrolizumab 84Specimen Handling 79Carboplatin 74Magnetic Resonance Spectroscopy 71Biopsy 58Nivolumab 55Cisplatin 55Paclitaxel 46Cyclophosphamide 44durvalumab 37Radiotherapy 36Radiation 35Rituximab 34olaparib 33Etoposide 33Dexamethasone 33Ipilimumab 30Gemcitabine 30Lenalidomide 28Taxes 27Pemetrexed 27Doxorubicin 27Docetaxel 27Bevacizumab 24Prednisone 23Cytarabine 23X-Rays 22Trastuzumab 21cabozantinib 20Disulfides 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Has results × Radiation Dose Hypofractionation × Clear all
NCT03972930 2026-05-12

Hypofractionated Radiotherapy for Soft Tissue Sarcomas

University of Wisconsin, Madison

Phase 2 Active not recruiting
48 enrolled 10 charts
Sarcoma

Sarcoma

NCT01266642 2026-03-11

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
301 enrolled 9 charts
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03796767 2026-01-28

SOAR

University of Utah

Phase 2 Active not recruiting
20 enrolled 26 charts
Genitourinary

Lymphatic Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡